Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect.
Osteoarthritis is an extremely common disease. However, it lacks effective nonsurgical treatments. Molecular docking has been widely used in drug discovery. However, no studies focus on screening anti-osteoarthritis compounds using molecular docking. This study aimed to screen potential anti-osteoar...
Saved in:
| Main Authors: | Tian-Wang Zhu, Yu Zheng, Rui-Xin Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0319686 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Screening potential anti-osteoarthritis compounds using molecular docking based on MAPK and NFκB pathways and validating their anti-osteoarthritis effect.
by: Tian-Wang Zhu, et al.
Published: (2025-01-01) -
Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways
by: Liang Zhu, et al.
Published: (2025-02-01) -
A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling
by: Hyemi Lee, et al.
Published: (2025-07-01) -
Fucosterol exerts an anti-atherosclerotic action via NF-κB and p38/Erk MAPK signaling pathways
by: Tiancheng Liu, et al.
Published: (2025-06-01) -
Anti‐inflammatory properties of ophioglonin derived from the fern Ophioglossum vulgatum L. via inactivating NF‐κB and MAPK signaling pathways
by: Xiaoqing Zhu, et al.
Published: (2025-01-01)